Snyder Capital Management L P Sells 16,798 Shares of Cabot Corporation $CBT

Snyder Capital Management L P trimmed its stake in shares of Cabot Corporation (NYSE:CBT) by 1.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,003,971 shares of the specialty chemicals company’s stock after selling 16,798 shares during the quarter. Cabot comprises approximately 1.4% of Snyder Capital Management L P’s investment portfolio, making the stock its 24th biggest position. Snyder Capital Management L P’s holdings in Cabot were worth $76,352,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank bought a new position in shares of Cabot in the second quarter valued at about $51,710,000. AQR Capital Management LLC boosted its holdings in shares of Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after buying an additional 478,702 shares during the period. American Century Companies Inc. grew its stake in Cabot by 11.1% in the 2nd quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock valued at $124,855,000 after buying an additional 166,460 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after acquiring an additional 108,645 shares during the period. Finally, Victory Capital Management Inc. lifted its position in Cabot by 259.2% during the third quarter. Victory Capital Management Inc. now owns 142,404 shares of the specialty chemicals company’s stock worth $10,830,000 after acquiring an additional 102,764 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Price Performance

Cabot stock opened at $75.10 on Thursday. The firm has a market cap of $3.92 billion, a PE ratio of 13.15, a price-to-earnings-growth ratio of 9.81 and a beta of 0.86. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09. The stock’s fifty day moving average price is $72.65 and its two-hundred day moving average price is $71.53. Cabot Corporation has a one year low of $58.33 and a one year high of $89.15.

Cabot (NYSE:CBT) last released its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.13. The company had revenue of $849.00 million for the quarter, compared to analyst estimates of $889.11 million. Cabot had a return on equity of 22.82% and a net margin of 8.62%.Cabot’s quarterly revenue was down 11.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.76 EPS. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, research analysts expect that Cabot Corporation will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Friday, February 27th will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Friday, February 27th. Cabot’s dividend payout ratio (DPR) is currently 31.52%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CBT. JPMorgan Chase & Co. reduced their price objective on Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a report on Friday, November 28th. Mizuho set a $75.00 price target on Cabot and gave the stock a “neutral” rating in a report on Wednesday, February 4th. Jefferies Financial Group restated a “buy” rating and issued a $85.00 price target on shares of Cabot in a research note on Wednesday, February 4th. Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. Finally, UBS Group lifted their target price on Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $73.75.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.